Hormone replacement therapy, body mass index and asthma in perimenopausal women: A cross sectional survey

Thorax

Volumn 61, Issue 1, 2006, Pages 34-40

  Gomez Real F ^a   Svanes, C ^b   Bjornsson E H ^c   Franklin, K ^d   Gislason, D ^c   Gislason, T ^c   Gulsvik, A ^b   Janson, C ^e   Jogi R ^f   Kiserud, T ^b   Norback D ^e   Nystrom L ^d   Toren K ^g   Wentzel Larsen, T ^a   Omenaas, E ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^d UMEÅ UNIVERSITY   (Sweden)

^e UPPSALA UNIVERSITY   (Sweden)

^f TARTU UNIVERSITY HOSPITAL   (Estonia)

^g SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLERGIC ASTHMA; ASTHMA; BODY MASS; CLIMACTERIUM; CONTROLLED STUDY; DENMARK; ESTONIA; FEMALE; HAY FEVER; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; ICELAND; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NORWAY; OBESITY; POSTAL MAIL; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SWEDEN; WHEEZING;

ADULT; ASTHMA; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; PERIMENOPAUSE; QUESTIONNAIRES; RHINITIS, ALLERGIC, SEASONAL; SMOKING;

EID: 30844459930     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2005.040881     Document Type: Review

References (38)

1. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
2. Cushman M, Legault C, Barrett-Connor E, et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation 1999;100:717-22.
3. Troisi RJ, Speizer FE, Willett WC, et al. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study. Am J Respir Crit Care Med 1995;152:1183-8.
4. Barr RG, Wentowski CC, Grodstein F, et al. Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive pulmonary disease. Arch Intern Med 2004;164:379-86.
5. Lange P, Parner J, Prescott E, et al. Exogenous female sex steroid hormones and risk of asthma and asthma-like symptoms: a cross sectional study of the general population. Thorax 2001;56:613-6.
6. 1 in elderly women. Am J Respir Crit Care Med 2001;163:423-8.
7. Kos-Kudla B, Ostrowska Z, Marek B, et al. Effects of hormone replacement therapy on endocrine and spirometric parameters in asthmatic postmenopausal women. Gynecol Endocrinol 2001;15:304-11.
8. Pata Ö. The effects of hormone replacement therapy type on pulmonary functions in postmenopausal women. Maturitas 2003;46:213-8.
9. Grodstein F, Clarkson TB, Manson JE. Understanding the divergent data on postmenopausal hormone therapy. N Engl J Med 2003;348:645-50.
10. Fernandez-Real JM, Sanchis D, Ricart W, et al. Plasma oestrone-fatty acid ester levels are correlated with body fat mass in humans. Clin Endocrinol (Oxf) 1999;50:253-60.
11. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-11.
12. Figueroa A, Going SB, Milliken LA, et al. Body composition modulates the effects of hormone replacement therapy on growth hormone and insulin-like growth factor-I levels in postmenopausal women. Gynecol Obstet Invest 2002;54:201-6.
13. Kalish GM, Barrett-Connor E, Laughlin GA, et al. Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial. J Clin Endocrinol Metab 2003;88:1646-52.
14. Lindheim SR, Presser SC, Ditkoff EC, et al. A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin. Fertil Steril 1993;60:664-7.
15. Balzano G, Fuschillo S, Melillo G, et al. Asthma and sex hormones. Allergy 2001;56:13-20.
16. Gunnbjornsdottir MI, Omenaas E, Gislason T, et al. Obesity and nocturnal gastro-oesophageal reflux are related to onset of asthma and respiratory symptoms. Eur Respir J 2004;24:116-21.
17. Shaheen SO, Sterne JA, Montgomery SM, et al. Birth weight, body mass index and asthma in young adults. Thorax 1999;54:396-402.
18. Comargo CA Jr, Weiss ST, Zhang S, et al. Prospective study of body mass index, weight change, and risk or adult-onset asthma in women. Arch Intern Med 1999;159:2582-8.
19. Simpson E, Rubin G, Clyne C, et al. The role of local estrogen biosynthesis in males and females. Trends Endocrinol Metab 2000;11:184-8.
20. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047-59.
21. Topo P, Koster A, Holte A, et al. Trends in the use of climacteric and postclimacteric hormones in Nordic countries. Maturitas 1995;22:89-95.
22. Svanes C, Real FG, Gislason T, et al. Association of asthma and hay fever with irregular menstruation. Thorax 2005;60:445-50.
23. Burney PG, Luczynska C, Chinn S, et al. The European Community Respiratory Health Survey. Eur Respir J 1994;7:954-60.
24. Speroff L, Glass RH, Kase NG. Menopause and the perimenopausal transition. In: Mitchell C, ed. Clinical gynecologic endocrinology and infertility. 6th ed. Baltimore: Lippincott Williams & Wilkins, 1999:643-724.
25. Pekkanen J, Sunyer J, Anto J, et al. Operational definitions of asthma in studies on its aetiology. Eur Respir J 2005;26:1-9.
26. Key TJ, Pike MC, Brown JB, et al. Cigarette smoking and urinary oestrogen excretion in premenopausal and post-menopausal women. Br J Cancer 1996;74:1313-6.
27. Espeland MA, Stefanick ML, Kritz-Silverstein D, et al. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators. J Clin Endocrinol Metab 1997;82:1549-56.
28. Harlow SD, Crawford SL, Sommer B, et al. Self-defined menopausal status in a multi-ethnic sample of midlife women. Maturitas 2000;36:93-112.
29. Bruning PF, Bonfrer JM, Hart AA, et al. Body measurements, estrogen availability and the risk of human breast cancer: a case-control study. Int J Cancer 1992;51:14-9.
30. Barrett-Connor E, Frette C. NIDDM, impaired glucose tolerance, and pulmonary function in older adults. The Rancho Bernardo Study. Diabetes Care 1996;19:1441-4.
31. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004;25:4-7.
32. Fernandez-Real JM, Broch M, Richart C, et al. CD14 monocyte receptor involved in the inflammatory cascade and insulin sensitivity. J Clin Endocrinol Metab 2003;88:1780-4.
33. Engstrom G, Hedblad B, Nilsson P, et al. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med 2003;253:574-81.
34. Davis WA, Knuiman M, Kendall P, et al. glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2004;27:752-7.
35. Lawlor DA, Ebrahim S, Smith GD. Associations of measures of lung function with insulin resistance and type 2 diabetes: findings from the British Women's Heart and Health Study. Diabetologia 2004;47:195-203.
36. Kirsch EA, Yuhanna IS, Chen Z, et al. Estrogen acutely stimulates endothelial nitric oxide synthase in H441 human airway epithelial cells. Am J Respir Cell Mol Biol 1999;20:658-66.
37. Keller AC, Rodriguez D, Russo M. Nitric oxide paradox in asthma. Mem Inst Oswaldo Cruz 2005;100(Suppl 1):19-23.
38. Simpson ER, Misso M, Hewitt KN, et al. Estrogen-the good, the bad, and the unexpected. Endocr Rev 2005;26:322-30.